Open Access Research article

Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran

Shekoufeh Nikfar1*, Abbas Kebriaeezadeh2, Reza Majdzadeh3 and Mohammad Abdollahi2

Author Affiliations

1 Iran Drug Selecting Committee Secretary, Drug Regulatory Affairs, Deputy of Food & Drug, Ministry of Health & Medical Education, Tehran, Iran

2 Department of Toxicology & Pharmacology, Faculty of Pharmacy, and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran

3 Department of Epidemiology & Biostatistics, School of Public Health and Institute of Public Health Research, Tehran University of Medical Sciences, Tehran, Iran

For all author emails, please log on.

BMC International Health and Human Rights 2005, 5:5  doi:10.1186/1472-698X-5-5

Published: 10 May 2005

Additional files

Additional File 1:

The scattergram of decision makers' point of view. The relation between each question and four indicators of NDP including: "Efficacy and Safety", "Affordability", "Availability and Accessibility" and "Rationality in use" have been asked and in case of each positive relation, the member of IDSC was asked to give a score from 1–5 for that indicator and for negative answer we considered the score of zero for it. Related to the point which obtained from the IDSC's opinion, any "yes" answer for each question could acquire scores in the range of +1 to +5 and the answer "no" got score 0 for each indicator. Their weighted questionnaire was filled out for each member separately and the results were reported by means of percentage of agreement.

Format: PDF Size: 18KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data